主页 > 医学讨论 >
【medical-news】使用普兰林肽治疗1型糖尿病的满意
使用普兰林肽治疗1型糖尿病的满意度更高 （ 医学会）
February 5, 2007 — Patients with type 1 diabetes had greater satisfaction with treatment after receiving pramlintide compared with placebo, according to the results of a study reported in the February issue of Diabetes Care.
2007年2月5日－在糖尿病治疗2月刊上的一篇研究报道指出，1型糖尿病患者对使用普兰林肽的治疗效果比使用安慰剂更满意。
"Pramlintide, a synthetic amylin analog indicated as an adjunctive treatment to insulin in patients with type 1 and 2 diabetes, acutely reduces postprandial glucose fluctuations and enhances satiety," write David G. Marrero, PhD, of the Indiana University School of Medicine in Indianapolis, and colleagues. "Long-term, adjunctive pramlintide therapy decreases A1C [glycated hemoglobin] with concomitant reductions in insulin use and body weight in patients with type 1 and type 2 diabetes. The primary aim of this end-of-study survey was to evaluate, under double-blind conditions, the effects of premeal subcutaneous pramlintide versus placebo injections on aspects of treatment satisfaction including perceived improvement [标签:content1][标签:content2]
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-02-20 17:11
医学,生命科学网